T. Bettuzzi, “Evolution of Drug Survival with Biological Agents and Apremilast Between 2012 and 2018 in Patients with Psoriasis from the PsoBioTeq Cohort”, Acta Derm Venereol, vol. 102, p. adv00665, Mar. 2022.